Talk # Abstract # Title/Author

82

11346

Complications And Outcome After Surgical Treatment Of Pelvic Sarcomas – Does Competing Risk Add To Treatment Considerations?
Reinhard Windhager, MD

83

11313

Morbidity, Mortality And Blood Loss Associated With Pelvic And Sacral Tumour Surgery
Michael Parry, FRCS (ORTHO), MD

84

11146

Resection Of The Acetabulum And Pelvis: Should We Still Offer Reconstructive Options?
Joseph Benevenia, MD

85

11421

Functional Outcome Following “No Reconstruction” In Patients Undergoing Periacetabular (Type-Ii) Pelvic Resection
Shah Alam Khan, MS, DNB, MRCSEd, FRCS, M.Ch.Orth

86

11160

Male And Female Sexual Dysfunction Following Pelvic Tumor Surgery--Sexual Dysfunction Following Pelvis Surgery
Ernest U Conrad III, MD

87

11474

Intrapelvic And Lumbopelvic Reconstruction Outcomes After Acetabulum-Sparing Tumor Resections
Harzem Ozger

88

11157

Functional Outcome Following Total Sacrectomies Without Spino-Pelvic Reconstruction
Piya Kiatisevi

89

10129

Sacral Chordoma: A Clinical Review Of 157 Cases With 30-Year Experience In A Single Institute
Xin Sun

90

10716

Conditional Survival And Functional Outcome Following Surgical Treatment For Sacral Chordoma: A Monocentric Retrospective Review Of 115 Consecutive Cases
Tao Ji, MD

91

11152

Surgical Strategies In Patients With Spinal Giant Cell Tumor: Twelve-Year’S Clinical Experience And Outcomes
Xin Sun

92

11380

Limb Lengthening After Internal Hemipelvectomy With The Fitbone-System
Rainer Baumgart, MD

93

11150

Intra-Aortic Balloon Occlusion To Prevent Bleeding In Pelvic Tumours: A Case Control Study
Michele Boffano, MD

94

11176

Giant Cell Tumor Of The Sacrum Treated With Conservative Surgery: 35 Years’ Experience
Chandhanarat Chandhanayingyong, MD

95

10059

Microwave Ablation Of Pelvic Malignant Bone Tumors
Qingyu Fan

96

11266

The Effect Of Surgical Margins On Local Recurrence And Survival After Resection Of High-Grade Soft Tissue Sarcomas Of The Extremities: Through The Eyes Of A Multi-State Model.
Michiel Van De Sande, MD, PHD

97

11323

Clinical Outcomes Of Unplanned Soft Tissue Sarcoma Excision In Comparison With Primary Planned Excision At Sarcoma Center; The Impact Of Residual Tumor In Re-Excision Specimen
Jungo Imanishi

98

11305

Locally Recurrent Soft Tissue Sarcoma: Outcomes With Re-Irradiation And/Or Surgical Excision
Anthony M. Griffin, MSc

99

11310

What Is The Significance Of A Fungating Soft Tissue Sarcoma?
Michael Parry, FRCS (ORTHO), MD

100

11121

Fdg Pet-Ct Response After Neoadjuvant Chemotherapy Continues To Predict Progression Free Survival At Mid-Term In Prospective Trial For Soft Tissue Sarcomas
Edward Y Cheng, MD

101

11376

Brachy Vac Treatment Of Superficial Malignancies- Results Of A Consecutive Case Series
Richard Louis McGough, MD

102

11255

Retrospective Review Of The Adequacy Of Community Magnetic Resonance Imaging (Mri) For Soft Tissue Sarcoma In The Periphery
David Joyce, MD

103

11236

Vancomycin Powder Reduces Risk Of Wound Complication In Orthopaedic Tumor Surgery
Christina J Gutowski, MD

104

11293

Myxofibrosarcoma: A Difficult-To Treat Soft Tissue Sarcoma - Considerations After 85 Patients
Giovanni Beltrami, MD

105

11250

Intraoperative Differentiation During Soft Tissue Sarcoma Excision Using Near Infrared Autofluorescence Spectroscopy
John Q Nguyen

106

11445

The Influence Of Diabetes, Obesity & Anatomic Location On The Development Of Post-Operative Wound Infections Following Soft Tissue Sarcoma Resection: A Multi-Institutional Study
Jeremy White, MD

107

11283

Does The Use Of Wound Vacuum Assisted Closure (Vac) Therapy Increase The Risk Of Local Recurrence After Sarcoma Excision?
Phillip A Taylor, MD

108

10694

Treatment Of Sarcoma Lung Metastases With External Beam Radiotherapy: Experience At A Tertiary Referral Center
Adam Lindsay, MD

109

10769

A Novel System For The Surgical Staging Of Primary High-Grade Osteosarcoma: The Birmingham Classification
Lee Jeys, FRCS

110

10873

Development And Validation Of A Pretreatment Prognostic Index To Predict Death And Lung Metastases For Extremity Osteosarcoma
Jian Tu

111

11183

Post-Metastasis Survival In High-Grade Extremity Osteosarcoma: A Retrospective Analysis Of Prognostic Factors Of 126 Patients.
Wanlim Kim

112

11270

The Role Of 18F-Fdg Pet/Ct For The Detection Of Recurrent Osteosarcoma
Pietro Ruggieri, MD

113

11363

Why Can’T We All Speak The Same Language? An Analysis Of The Definition And Significance Of Margins In The Euramos-1 Trial
Robert John Grimer

114

11262

The Effect Of Surgical Timing On The Outcome Of Localized Extremity Osteosarcoma
Soo-Yong Lee

115

11439

Osteofibrous-Dysplasia-Like-Adamantinoma And Adamantinoma: A Clinical, Radiological And Histological Analysis Of 82 Cases
Emile M Schutgens, MD

116

11259

Prognostic Factors And Outcomes Of Dedifferentiated Chondrosarcoma – A Single Institution Experience
Christopher John Matthews, MD

117

11495

Is Radiation Worth The Risk For Diffuse Large B-Cell Lymphoma Of Bone In The Era Of Chop-R Therapy?
Nicholas Bernthal, MD

118

10610

Is Needle Biopsy Clinically Useful In Pre-Operative Grading Of Central Chondrosarcoma Of Pelvis And Long Bones?
Pablo Roitman, MD

119

10874

Is Pet-Ct An Accurate Method For The Differential Diagnosis Between Chondroma And Chondrosarcoma?
Reynaldo Jesus-Garcia, MD

120

10010

Tumor Necrosis: Does It Define The Need For Post Operative Radiotherapy In Ewing's Sarcoma?
Ajay Puri, MD

121

10655

Periosteal Osteosarcoma; The University Of Florida Experience
Chung Chan, MBBS

122

10665

Adamantinoma Of The Long Bones_ A Retrospective Study Of 18 Cases
Zhiping Deng, MD

123

10991

Survival In Mesenchymal Chondrosarcoma: 205 Cases From The Seer Database
Lukas Nystrom, MD

124

11423

Do We Need To Remove The Biopsy Tract In Patients Undergoing Surgery Following Neo- Adjuvant Chemotherapy For Primary Bone Tumors?
Shah Alam Khan, MS, DNB, MRCSEd, FRCS, M.Ch.Orth

125

10872

Patterns Of Local Recurrence And Metastatic Progression Following Treatment Of Bone Sarcomas
Cara Cipriano

126

11448

Ct Data Evaluation Of Proximal Femur Malignant Tumors
Oleg Vyrva, MD

127

11463

Surgical Treatment Of Conventional Primary Central Chondrosarcoma Of Pelvic Bone: A Multicenter Study In 164 Patients
Sander Dijkstra, MD

128

11144

Ewing Sarcoma: Only Patients With 100% Of Necrosis After Adjuvant Chemotherapy Should Be Classified As Good Responders.
Jose Ignacio Albergo, MD